Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
2.490
-0.090 (-3.49%)
At close: Oct 16, 2026, 4:00 PM EDT
2.510
+0.020 (0.80%)
After-hours: Oct 16, 2026, 7:44 PM EDT
Niagen Bioscience Revenue
Niagen Bioscience had revenue of $29.79M in the quarter ending June 30, 2026, a decrease of -4.28%. This brings the company's revenue in the last twelve months to $129.08M, up 10.99% year-over-year. In the year 2025, Niagen Bioscience had annual revenue of $129.42M with 29.95% growth. That makes Niagen Bioscience the 20,731st largest company in the world by revenue and 3,139th in the United States.
Revenue (ttm)
$129.08M
Revenue Growth
+10.99%
P/S Ratio
1.53
Revenue / Employee
$1,103,282
Employees
117
Market Cap
197.44M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 129.42M | 29.83M | 29.95% |
| Dec 31, 2024 | 99.60M | 16.03M | 19.18% |
| Dec 31, 2023 | 83.57M | 11.52M | 15.99% |
| Dec 31, 2022 | 72.05M | 4.60M | 6.82% |
| Dec 31, 2021 | 67.45M | 8.19M | 13.82% |
| Dec 31, 2020 | 59.26M | 12.97M | 28.01% |
| Dec 31, 2019 | 46.29M | 14.73M | 46.69% |
| Dec 31, 2018 | 31.56M | 10.36M | 48.85% |
| Dec 30, 2017 | 21.20M | -463.65K | -2.14% |
| Dec 31, 2016 | 21.66M | 3.78M | 21.13% |
| Jan 2, 2016 | 17.88M | 2.57M | 16.79% |
| Jan 3, 2015 | 15.31M | 5.15M | 50.71% |
| Dec 28, 2013 | 10.16M | -1.45M | -12.48% |
| Dec 29, 2012 | 11.61M | 3.50M | 43.12% |
| Dec 31, 2011 | 8.11M | 546.24K | 7.22% |
| Jan 1, 2011 | 7.57M | 1.79M | 30.95% |
| Jan 2, 2010 | 5.78M | 1.27M | 28.22% |
| Jan 3, 2009 | 4.51M | -247.77K | -5.21% |
| Dec 29, 2007 | 4.75M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| B&G Foods | 1.77B |
| Oatly Group AB | 925.00M |
| USANA Health Sciences | 913.36M |
| Nature's Sunshine Products | 492.02M |
| BRC Inc. | 429.70M |
| Beyond Meat | 258.85M |
| Lifeway Foods | 242.41M |
| Prenetics Global | 154.59M |
NAGE News
- 3 days ago - Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026 - Business Wire
- 10 days ago - Andrew Shao, Ph.D., Senior Vice President of Global Regulatory and Scientific Affairs at Niagen Bioscience, Honored with the 2026 Annette Dickinson Trailblazer Award by Radicle Science and Council for Responsible Nutrition (CRN) - Business Wire
- 12 days ago - Niagen Bioscience to Present at LD Micro 20th Annual Main Event - Business Wire
- 17 days ago - Niagen Bioscience launches ‘Don’t Get Old. Age Better.’ campaign - TheFly
- 17 days ago - Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better. - Business Wire
- 18 days ago - Niagen Bioscience enters start-up agreement with Mass General Brigham - TheFly
- 18 days ago - Niagen Bioscience Announces Start-Up Agreement With Mass General Brigham (MGB) Investigators For First-Of-Its-Kind Healthy Aging Clinical Trial - Business Wire
- 27 days ago - Niagen Bioscience announces publication of preclinical study on CD38 - TheFly